Literature DB >> 18769927

Neurosurgical aspects of childhood hypophosphatasia.

H Collmann1, E Mornet, S Gattenlöhner, C Beck, H Girschick.   

Abstract

OBJECTIVE: Hypophosphatasia (HPP; MIM241510) is a rare inborn error of bone metabolism of recessive inheritance. It is caused by mutations in the gene encoding the tissue-nonspecific alkaline phosphatase. Apart from problems in bone mineralization, growth failure, and premature loss of decidual teeth, the infantile and the childhood types of HPP are associated with premature fusion of cranial sutures. PATIENTS: We report on seven children affected with infantile and childhood HPP who presented with craniosynostosis.
RESULTS: Neurosurgical intervention was necessary in four of them because of intracranial hypertension. In one of these, severe dural calcification posed an unexpected problem during surgery. Secondary ectopia of the cerebellar tonsils were detected in five of the seven patients and caused hydrosyringomyelia in one of them.
CONCLUSIONS: Since cranial sutures are frequently involved in infantile and childhood HPP, a multidisciplinary approach for the clinical care is necessary, including long-term neurosurgical surveillance.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18769927     DOI: 10.1007/s00381-008-0708-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  17 in total

1.  Severe hypophosphatasia due to mutations in the tissue-nonspecific alkaline phosphatase (TNSALP) gene.

Authors:  C Stoll; M Fischbach; J Terzic; Y Alembik; M O Vuillemin; E Mornet
Journal:  Genet Couns       Date:  2002

Review 2.  Hypophosphatasia: the mutations in the tissue-nonspecific alkaline phosphatase gene.

Authors:  E Mornet
Journal:  Hum Mutat       Date:  2000       Impact factor: 4.878

3.  Hypophosphatasia.

Authors:  R I Macpherson; M Kroeker; C S Houston
Journal:  J Can Assoc Radiol       Date:  1972-03

Review 4.  Hydrocephalus in craniosynostosis: a review.

Authors:  H Collmann; N Sörensen; J Krauss
Journal:  Childs Nerv Syst       Date:  2005-04-27       Impact factor: 1.475

5.  Glu274Lys/Gly309Arg mutation of the tissue-nonspecific alkaline phosphatase gene in neonatal hypophosphatasia associated with convulsions.

Authors:  O Reish; T Dolfin; S Arnon; R Regev; G Grinshpan; M Yamazaki; K Ozono
Journal:  J Inherit Metab Dis       Date:  2002-02       Impact factor: 4.982

6.  Characterization of 11 novel mutations in the tissue non-specific alkaline phosphatase gene responsible for hypophosphatasia and genotype-phenotype correlations.

Authors:  Isabelle Brun-Heath; Agnes Taillandier; Jean-Louis Serre; Etienne Mornet
Journal:  Mol Genet Metab       Date:  2004-12-19       Impact factor: 4.797

7.  Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene.

Authors:  Sara Baumgartner-Sigl; Edda Haberlandt; Steven Mumm; Sabine Scholl-Bürgi; Consolato Sergi; Lawrence Ryan; Karen L Ericson; Michael P Whyte; Wolfgang Högler
Journal:  Bone       Date:  2007-02-14       Impact factor: 4.398

8.  Chronic tonsillar herniation in Crouzon's and Apert's syndromes: the role of premature synostosis of the lambdoid suture.

Authors:  G Cinalli; D Renier; G Sebag; C Sainte-Rose; E Arnaud; A Pierre-Kahn
Journal:  J Neurosurg       Date:  1995-10       Impact factor: 5.115

Review 9.  Radiographic manifestations of congenital anomalies of the skull.

Authors:  S B Kaplan; S S Kemp; K S Oh
Journal:  Radiol Clin North Am       Date:  1991-03       Impact factor: 2.303

10.  Effective NSAID treatment indicates that hyperprostaglandinism is affecting the clinical severity of childhood hypophosphatasia.

Authors:  H J Girschick; P Schneider; I Haubitz; O Hiort; H Collmann; M Beer; Y S Shin; H W Seyberth
Journal:  Orphanet J Rare Dis       Date:  2006-06-28       Impact factor: 4.123

View more
  31 in total

1.  Clinical utility gene card for: hypophosphatasia.

Authors:  Etienne Mornet; Christine Beck; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2010-10-27       Impact factor: 4.246

2.  Clinical utility gene card for: hypophosphatasia - update 2013.

Authors:  Etienne Mornet; Christine Hofmann; Agnès Bloch-Zupan; Hermann Girschick; Martine Le Merrer
Journal:  Eur J Hum Genet       Date:  2013-08-07       Impact factor: 4.246

3.  Whole-body MRI in the childhood form of hypophosphatasia.

Authors:  C Beck; H Morbach; C Wirth; M Beer; H J Girschick
Journal:  Rheumatol Int       Date:  2010-04-10       Impact factor: 2.631

Review 4.  Hypophosphatasia.

Authors:  Agnès Linglart; Martin Biosse-Duplan
Journal:  Curr Osteoporos Rep       Date:  2016-06       Impact factor: 5.096

Review 5.  Hypophosphatasia - aetiology, nosology, pathogenesis, diagnosis and treatment.

Authors:  Michael P Whyte
Journal:  Nat Rev Endocrinol       Date:  2016-02-19       Impact factor: 43.330

6.  Tissue-nonspecific alkaline phosphatase deficiency causes abnormal craniofacial bone development in the Alpl(-/-) mouse model of infantile hypophosphatasia.

Authors:  Jin Liu; Hwa Kyung Nam; Cassie Campbell; Kellen Cristina da Silva Gasque; José Luis Millán; Nan E Hatch
Journal:  Bone       Date:  2014-07-09       Impact factor: 4.398

7.  Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.

Authors:  Michael P Whyte; Cheryl Rockman-Greenberg; Keiichi Ozono; Richard Riese; Scott Moseley; Agustin Melian; David D Thompson; Nicholas Bishop; Christine Hofmann
Journal:  J Clin Endocrinol Metab       Date:  2015-11-03       Impact factor: 5.958

Review 8.  Hypophosphatasia: an overview of the disease and its treatment.

Authors:  M L Bianchi
Journal:  Osteoporos Int       Date:  2015-08-06       Impact factor: 4.507

Review 9.  Rare bone diseases and their dental, oral, and craniofacial manifestations.

Authors:  B L Foster; M S Ramnitz; R I Gafni; A B Burke; A M Boyce; J S Lee; J T Wright; S O Akintoye; M J Somerman; M T Collins
Journal:  J Dent Res       Date:  2014-04-03       Impact factor: 6.116

Review 10.  Alkaline Phosphatase Replacement Therapy.

Authors:  Maria Luisa Bianchi; Silvia Vai
Journal:  Adv Exp Med Biol       Date:  2019       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.